Nephrology Conferences
Nephrology Conferences
Advertisement
Charlotte RobinsonWCN 2025 | February 10, 2025
Can SZC help with RAASi maximization without resultant hyperkalemia in patients with HFrEF and CKD?
Read More
Charlotte RobinsonWCN 2025 | February 10, 2025
Interim APPLAUSE-IgAN data showed that iptacopan was superior to placebo at reducing proteinuria at nine months.
Charlotte RobinsonWCN 2025 | February 6, 2025
Current eligibility criteria for simultaneous heart and kidney transplantation may be subject to eGFRcr errors.
Charlotte RobinsonWCN 2025 | February 6, 2025
How accurately and efficiently does artificial intelligence perform clinical prescreening compared with nephrologists?
Charlotte RobinsonWCN 2025 | February 6, 2025
The WRAPSODY stent may help restore circuit patency when stenosis or occlusion occurs within the AVG or AVF for hemodialysis.
Charlotte RobinsonWCN 2025 | February 6, 2025
A MAMS platform trial will examine use of antiproteinuric and immunomodulatory therapies in glomerular diseases.
Charlotte RobinsonWCN 2025 | February 6, 2025
Zigakibart for treatment of IgA nephropathy (IgAN) was well tolerated, reduced proteinuria, and stabilized eGFR at 76 weeks.
Charlotte RobinsonWCN 2025 | February 6, 2025
A clinical trial examined the relationship between steroid exposure and bone mineral density changes in children.
Charlotte RobinsonWCN 2025 | February 6, 2025
An analysis sought to determine the economic costs of treating SARS-CoV-2 infection among kidney transplant recipients.
Charlotte RobinsonWCN 2025 | January 10, 2025
The International Society of Nephrology (ISN) has announced the 2025 recipients of the ISN Awards and ISN Pioneer Awards.
Charlotte RobinsonASN Kidney Week 2024 | December 11, 2024
Obinutuzumab reduced proteinuria in patients with FSGS who were treatment-resistant or on immunosuppressive therapy.
Charlotte RobinsonASN Kidney Week 2024 | December 12, 2024
RGLS8429 increases urinary PC1 and PC2 proteins, which may help reduce height-adjusted total kidney volume in ADPKD.
Charlotte RobinsonASN Kidney Week 2024 | December 9, 2024
Researchers evaluated the efficacy of sparsentan in a subset of patients with genetic focal segmental glomerulosclerosis.
Charlotte RobinsonASN Kidney Week 2024 | December 6, 2024
Could pravastatin slow the rate of increase in height-adjusted total kidney volume in adults with ADPKD?
Charlotte RobinsonASN Kidney Week 2024 | December 5, 2024
A study examined the efficacy of adding SZC to allow patients with stage 3-4 DKD to maintain treatment with RAASi.
Charlotte RobinsonASN Kidney Week 2024 | December 4, 2024
Researchers assessed the safety and efficacy of bardoxolone methyl (BARD) in patients with ADPKD.
Vlado Perkovic, MBBS, PhDASN Kidney Week 2024 | December 4, 2024
Vlado Perkovic spoke about findings from the FLOW, APPLAUSE-IgAN, and CREDENCE trials presented at ASN Kidney Week.
Charlotte RobinsonASN Kidney Week 2024 | December 3, 2024
Researchers studied the efficacy and safety of dapagliflozin in patients with chronic kidney disease stages 4 and 5.
Charlotte RobinsonASN Kidney Week 2024 | December 2, 2024
A study examined whether the relationship between hyponatremia and higher mortality and rehospitalization is causal.
Charlotte RobinsonASN Kidney Week 2024 | November 29, 2024
Researchers studied risk of postoperative AKI with perioperative hypotension- versus hypertension-avoidance strategies.
Advertisement
Advertisement
Advertisement
Latest News

February 18, 2025